![]() 4-氧代哌啶-1-羧酸异丙酯结构式
![]() |
常用名 | 4-氧代哌啶-1-羧酸异丙酯 | 英文名 | 1-Piperidinecarboxylic acid,4-oxo-,1-methylethyl ester |
---|---|---|---|---|
CAS号 | 190013-27-5 | 分子量 | 185.22000 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C9H15NO3 | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
中文名 | 4-氧代哌啶-1-羧酸异丙酯 |
---|---|
英文名 | Isopropyl 4-oxo-1-piperidinecarboxylate |
中文别名 | 1-异丙氧羰基-4-哌啶酮 |
英文别名 | 更多 |
分子式 | C9H15NO3 |
---|---|
分子量 | 185.22000 |
精确质量 | 185.10500 |
PSA | 46.61000 |
LogP | 1.13420 |
~49% 4-氧代哌啶-1-羧酸异丙酯 190013-27-5 |
文献:Mitsubishi Tanabe Pharma Corporation Patent: EP2390254 A1, 2011 ; Location in patent: Page/Page column 64 ; EP 2390254 A1 |
~% 4-氧代哌啶-1-羧酸异丙酯 190013-27-5 |
文献:BRISTOL-MYERS SQUIBB COMPANY Patent: WO2008/137436 A1, 2008 ; Location in patent: Page/Page column 85-86 ; WO 2008/137436 A1 |
~% 4-氧代哌啶-1-羧酸异丙酯 190013-27-5 |
文献:BOEHRINGER INGELHEIM INTERNATIONAL GMBH; NEUROCRINE BIOSCIENCES, INC.; NOSSE, Bernd; ECKHARDT, Matthias; HIMMELSBACH, Frank; LANGKOPF, Elke; ASHWEEK, Neil J.; HARRIOTT, Nicole Patent: WO2014/19967 A1, 2014 ; |
4-氧代哌啶-1-羧酸异丙酯上游产品 4 | |
---|---|
4-氧代哌啶-1-羧酸异丙酯下游产品 0 |
4-Nitro-trans-zimtsaeure-isopropylester |
isopropyl 4-oxopiperidine-1-carboxylate |
4-nitro-trans-cinnamic acid isopropyl ester |
iso-propyl 4-nitrocinnamate |
2-Propenoic acid,3-(4-nitrophenyl)-,1-methylethyl ester |
4-oxopiperidine-1-carboxylic acid isopropyl ester |
isopropyl 3-(4-nitrophenyl)propenoate |